Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00177437
Status:
COMPLETED
Last Update Posted:
2007-12-13
First Post:
2005-09-12
Brief Title:
Home Screening for Chlamydia Surveillance
Sponsor:
University of Pittsburgh
Organization:
University of Pittsburgh
Study Overview
Official Title:
Home Screening for Chlamydia Surveillance
Status:
COMPLETED
Status Verified Date:
2007-12
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a randomized controlled trial to determine whether a home screening test for chlamydia and gonorrhea will lead to increased use of screening tests and increased detection of sexually transmitted diseases
Detailed Description:
This is a phase III randomized controlled trial We enrolled 403 young women from a variety of clinical settings and neighborhoods in the Pittsburgh PA region Women completed a baseline questionnaire and then were randomized to either an intervention group receive home testing kit every six months or to a control group receive a letter suggesting a clinic visit for screening Participants were followed for 2 years and medical chart abstraction was done to document tests done in clinical settings The final study end points were number of tests completed number of screening tests completed number of STDs detected and incident cases of pelvic inflammatory disease
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None